[1]
Velingker, A. and Lawande, D. 2020. Adverse drug reactions and treatment outcome analysis in multidrug resistant tuberculosis patients at a DOTS plus site. International Journal of Basic & Clinical Pharmacology. 9, 4 (Mar. 2020), 547–551. DOI:https://doi.org/10.18203/2319-2003.ijbcp20201174.